650 Workplaces Are in Danger: Vaccine Plant in Dresden Is Ahead of The
11 Articles
11 Articles
GSK produces vaccines against influenza and hepatitis. According to previous data, 2 million doses of vaccine are produced in Dresden per week.
After 115 years, vaccine production in Dresden is running out. The pharmaceutical company GlaxoSmithKline (GSK) plans to close its site with almost 650 employees by the summer of 2028.
The British pharmaceutical company GSK has announced the closure of its Dresden plant. Hundreds of employees are expected to lose their jobs.
The pharmaceutical company GlaxoSmithKline wants to close its traditional location in Dresden until the summer of 2028. Demand for vaccine is declining worldwide.
The British company announced the end of the 155-year-old Saxon Serum Plant
Here you will find information on the topic "Close-up plans". Read now "GSK wants to close the Dresden vaccine plant".
Coverage Details
Bias Distribution
- 67% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
